5 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Showing 5 of 5 clinical reviews.
A source-checked review of atorvastatin exposure and efficacy in East Asian patients, including conflicting pharmacokinetic evidence, current FDA labeling, and genotype-informed care.
An evidence-based review of atorvastatin efficacy differences in Black and African ancestry patients, covering pharmacogenomics, ethnicity-stratified trial data, and clinical dosing considerations.
East Asian patients metabolize atorvastatin differently due to SLCO1B1, CYP2C19, and ABCG2 variants. Learn how pharmacogenomics, ethnicity-stratified trial data, and current guidelines inform safer, more effective Lipitor dosing for East Asian patients.
East Asian patients taking atorvastatin (Lipitor) face distinct pharmacogenomic risks, different optimal starting doses, and ethnicity-specific myopathy thresholds. Here is what the clinical data says.
Atorvastatin dosing in Hispanic and Latino patients: ethnicity-stratified trial data, CYP3A4/SLCO1B1 pharmacogenomics, diabetes risk, and ACC/AHA guideline-concordant recommendations from the HealthRX.com medical team.